Table 3.
Unadjusted service utilization frequencies for the investigated preventive services among adult patients with hypertension or diabetes mellitus (n = 1659).
| Preventive services | Service utilization frequencies |
|
|---|---|---|
| % | 95%CI | |
| Measurement of blood pressure in 12 months | 97.9 | 97.2–98.6 |
| Measurement of serum glucose in 12 months | 80.2 | 78.3–82.2 |
| Measurement of serum lipid parameters in 12 months | 73.2 | 71.0–75.3 |
| Measurement of body weight in 24 months | 63.0 | 60.7–65.3 |
| Cervical cancer screening (women, 25–65 years) in 36 months | 62.7 | 58.4–67.1 |
| Measurement of urinary proteins in 12 months | 61.5 | 59.1–63.8 |
| Breast cancer screening (women, 45–65 years) in 24 months | 60.8 | 56.0–65.6 |
| Measurement of urinary creatinine in 12 months | 48.5 | 46.1–50.9 |
| Assessment of family history in 24 months | 40.3 | 38.0–42.7 |
| Prostate cancer screening (men, 65+ years) in 36 months | 38.6 | 32.4–44.8 |
| Test of visual acuity in 36 months | 36.2 | 33.9–38.5 |
| Assessment of dietary habits in 24 months | 33.5 | 31.2–35.8 |
| Measurement of waist circumference in 24 months | 32.9 | 30.7–35.2 |
| Examination for atherosclerosis in 24 months | 31.7 | 29.5–34.0 |
| Screening for alcohol misuse in 24 months | 29.5 | 27.3–31.7 |
| Assessment of smoking habits in 24 months | 24.7 | 22.6–26.8 |
| Oral cavity cancer screening in 24 months | 21.5 | 19.5–23.4 |
| Test for hearing loss in 36 months | 18.0 | 16.2–19.9 |
| Colorectal cancer screening (50–75 years) in 36 months | 18.0 | 15.6–20.4 |